Live lactic acid bacteria probiotics (VSL Pharmaceuticals)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameLive lactic acid bacteria probiotics (VSL Pharmaceuticals)
Drug Alias NameVSL-3VSL#3
ClassificationBiologicsNatural product/Extract > Microbial extract
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsDecompensated Liver CirrhosisPersian Gulf SyndromeAscites +[9
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesVsl Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesVsl Pharmaceuticals
Active IndicationsHepatic EncephalopathyIrritable Bowel SyndromePouchitis +[4
Inactive IndicationsDecompensated Liver CirrhosisPersian Gulf SyndromeAscites +[5

Other Information

ATC CodeA07FA01
Related LinksWikipedia